(Q40751157)

23 September 2017

title

Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas (English)

1 reference

23 September 2017

main subject

phase II clinical trial

0 references

1 reference

Chidiac T

1

1 reference

23 September 2017

Budd GT

2

1 reference

23 September 2017

Pelley R

3

1 reference

23 September 2017

Sandstrom K

4

1 reference

23 September 2017

McLain D

5

1 reference

23 September 2017

Elson P

6

1 reference

23 September 2017

Crownover R

7

1 reference

23 September 2017

Marks K

8

1 reference

23 September 2017

Muschler G

9

1 reference

23 September 2017

Joyce M

10

1 reference

23 September 2017

Zehr R

11

1 reference

23 September 2017

Bukowski R

12

1 reference

23 September 2017

publication date

1 August 2000

1 reference

Investigational New Drugs

23 September 2017

published in

1 reference

23 September 2017

volume

18

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

253-259

1 reference

Comparison of Regional Versus Systemic Chemotherapy with Adriamycin

23 September 2017

cites work

1 reference

12 December 2020

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

12 December 2020

Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs

1 reference

12 December 2020

Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multi-institutional phase II trial

1 reference

12 December 2020

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

12 December 2020

Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes

1 reference

12 December 2020

Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas

1 reference

12 December 2020

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

1 reference

12 December 2020

Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas

1 reference

12 December 2020

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes

1 reference

12 December 2020

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

12 December 2020

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

1 reference

12 December 2020

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

12 December 2020

Phase I trial of dose-intense liposome-encapsulated doxorubicin in patients with advanced sarcoma

1 reference

12 December 2020

Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).

1 reference

12 December 2020

A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas

1 reference

12 December 2020

Phase II evaluation of adriamycin in human neoplasia

1 reference

12 December 2020

Dose response evaluation of adriamycin in human neoplasia

1 reference

12 December 2020

Effect of liposomes on P-glycoprotein function in multidrug resistant cells

1 reference

12 December 2020

The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin

1 reference

12 December 2020

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule

1 reference

12 December 2020

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006429907449

1 reference

Dimensions Publication ID

23 September 2017

1047175539

0 references

1 reference